tm logo
Trademark Search
REBLOZYL

View On IC.GC.CA

REBLOZYL
REGISTERED

on 27 Jun 2019

Last Applicant/ Owned by

CELGENE CORPORATION

Route 206 & Province Line RoadPrinceton, NJ 08543

US

Serial Number

1822212 filed on 09th Feb 2017

Registration Number

TMA1033106 registered on 27th Jun 2019

Registration expiry Date

27th Jun 2029

Correspondent Address

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

REBLOZYL

Trademark usage description

pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoimmune disease, blood disease, cancer, art Read More

Classification Information

Class [005]
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoimmune disease, blood disease, cancer, arthritis in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations, namely, cytokine inhibitory drugs for use in the treatment of autoimmune diseases; pharmaceutical preparations, for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; blood tumors

Classification kind code

11

Mark Details

Serial Number

1822212

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 50
on 17th Aug 2018		Allowed
Submitted for opposition 51
on 17th Aug 2018		Allowance Notice Sent
Submitted for opposition 42
on 02th May 2018		Advertised
Submitted for opposition 26
on 12th Apr 2018		Approved
Submitted for opposition 27
on 21st Feb 2018		Approval Notice Sent
Submitted for opposition 22
on 21st Jul 2017		Search Recorded
Submitted for opposition 20
on 21st Jul 2017		Examiner's First Report
Submitted for opposition 31
on 13th Feb 2017		Formalized
Submitted for opposition 1
on 10th Feb 2017		Created
Submitted for opposition 30
on 09th Feb 2017		Filed